Daftari Inder k, Aghaian Elsa, O'Brien Joan M, Dillon William, Phillips Theodore L
Department of Radiation Oncology, University of California, San Francisco, California 94143, USA.
Med Phys. 2005 Nov;32(11):3355-62. doi: 10.1118/1.2068927.
The aim of this study is to (1) compare the delineation of the tumor volume for ocular melanoma on high-resolution three-dimensional (3D) T2-weighted fast spin echo magnetic resonance imaging (MRI) images with conventional techniques of A- and B-scan ultrasound, transcleral illumination, and placement of tantalum markers around tumor base and (2) to evaluate whether the surgically placed marker ring tumor delineation can be replaced by 3D MRI based tumor delineation. High-resolution 3D T2-weighted fast spin echo (3D FSE) MRI scans were obtained for 60 consecutive ocular melanoma patients using a 1.5 T MRI (GE Medical Systems, Milwaukee, WI), in a standard head coil. These patients were subsequently treated with proton beam therapy at the UC Davis Cyclotron, Davis, CA. The tumor was delineated by placement of tantalum rings (radio-opaque markers) around the tumor periphery as defined by pupillary transillumination during surgery. A point light source, placed against the sclera, was also used to confirm ring agreement with indirect ophthalmoscopy. When necessary, intraoperative ultrasound was also performed. The patients were planned using EYEPLAN software and the tumor volumes were obtained. For analysis, the tumors were divided into four categories based on tumor height and basal diameter. In order to assess the impact of high-resolution 3D T2 FSE MRI, the tumor volumes were outlined on the MRI scans by two independent observers and the tumor volumes calculated for each patient. Six (10%) of 60 patients had tumors, which were not visible on 3D MRI images. These six patients had tumors with tumor heights < or = 3 mm. A small intraobserver variation with a mean of (-0.22 +/- 4)% was seen in tumor volumes delineated by 3D T2 FSE MR images. The ratio of tumor volumes measured on MRI to EYEPLAN for the largest to the smallest tumor volumes varied between 0.993 and 1.02 for 54 patients. The tumor volumes measured directly on 3D T2 FSE MRI ranged from 4.03 to 0.075 cm3. with a mean of 0.87 +/- 0.84 cm3. The tumor shapes obtained from 3D T2 FSE MR images were comparable to the tumor shapes obtained using EYEPLAN software. The demonstration of intraocular tumor volumes with the high-resolution 3D fast spin echo T2 weighted MRI is excellent and provides additional information on tumor shape. We found a high degree of accuracy for tumor volumes with direct MRI volumetric measurements in uveal melanoma patients. In some patients with extra large tumors, the tumor base and shape was modified, because of the additional information obtained from 3D T2 FSE MR images.
(1)将高分辨率三维(3D)T2加权快速自旋回波磁共振成像(MRI)图像上眼黑色素瘤的肿瘤体积描绘与A超和B超、经巩膜透照以及在肿瘤基底周围放置钽标记物的传统技术进行比较;(2)评估手术放置的标记环肿瘤描绘是否可以被基于3D MRI的肿瘤描绘所取代。使用1.5T MRI(GE医疗系统公司,威斯康星州密尔沃基),通过标准头部线圈,对60例连续性眼黑色素瘤患者进行了高分辨率3D T2加权快速自旋回波(3D FSE)MRI扫描。这些患者随后在加利福尼亚州戴维斯市的加州大学戴维斯分校回旋加速器接受质子束治疗。在手术期间,通过在瞳孔透照所确定的肿瘤周边放置钽环(不透射线标记物)来描绘肿瘤。还使用一个靠在巩膜上的点光源来确认标记环与间接检眼镜检查结果的一致性。必要时,也进行术中超声检查。使用EYEPLAN软件对患者进行治疗计划并获得肿瘤体积。为了进行分析,根据肿瘤高度和基底直径将肿瘤分为四类。为了评估高分辨率3D T2 FSE MRI的影响,由两名独立观察者在MRI扫描上勾勒出肿瘤体积,并计算出每位患者的肿瘤体积。60例患者中有6例(10%)的肿瘤在3D MRI图像上不可见。这6例患者的肿瘤高度≤3mm。在3D T2 FSE MR图像描绘的肿瘤体积中,观察者内变异较小,平均值为(-0.22±4)%。54例患者中,MRI测量的肿瘤体积与EYEPLAN测量的最大肿瘤体积与最小肿瘤体积之比在0.993至1.02之间。直接在3D T2 FSE MRI上测量的肿瘤体积范围为4.03至0.075cm³,平均值为0.87±0.84cm³。从3D T2 FSE MR图像获得的肿瘤形状与使用EYEPLAN软件获得的肿瘤形状相当。高分辨率3D快速自旋回波T2加权MRI对眼内肿瘤体积的显示效果极佳,并提供了有关肿瘤形状的额外信息。我们发现,在葡萄膜黑色素瘤患者中,直接进行MRI体积测量对肿瘤体积的测量具有高度准确性。在一些患有超大肿瘤的患者中,由于从3D T2 FSE MR图像获得的额外信息,肿瘤基底和形状发生了改变。